These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7699711)

  • 1. Computer-aided molecular modeling, synthesis, and biological evaluation of 8-(benzyloxy)-2-phenylpyrazolo[4,3-c]quinoline as a novel benzodiazepine receptor agonist ligand.
    Wang CG; Langer T; Kamath PG; Gu ZQ; Skolnick P; Fryer RI
    J Med Chem; 1995 Mar; 38(6):950-7. PubMed ID: 7699711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationship studies at the benzodiazepine receptor (BZR): a comparison of the substitutent effects of pyrazoloquinolinone analogs.
    Fryer RI; Zhang P; Rios R; Gu ZQ; Basile AS; Skolnick P
    J Med Chem; 1993 May; 36(11):1669-73. PubMed ID: 8388472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel anellated pyrazoloquinolin-3-ones: synthesis and in vitro BZR activity.
    Ferlin MG; Chiarelotto G; Dall'Acqua S; Maciocco E; Mascia MP; Pisu MG; Biggio G
    Bioorg Med Chem; 2005 May; 13(10):3531-41. PubMed ID: 15848766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High affinity central benzodiazepine receptor ligands: synthesis and structure-activity relationship studies of a new series of pyrazolo[4,3-c]quinolin-3-ones.
    Savini L; Massarelli P; Nencini C; Pellerano C; Biggio G; Maciocco A; Tuligi G; Carrieri A; Cinone N; Carotti A
    Bioorg Med Chem; 1998 Apr; 6(4):389-99. PubMed ID: 9597183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tricyclic heteroaromatic systems. Synthesis and benzodiazepine binding activity of 1-substituted-3-methyl- and 3-phenylpyrazolo[4,5-c]quinolin-4-ones.
    Colotta V; Cecchi L; Melani F; Catarzi D; Filacchioni G; Martini C; Giannaccini G; Tonelli M; Lucacchini A
    Drug Des Discov; 1992 Jul; 8(4):325-39. PubMed ID: 1332785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and BZR affinity of pyrazolo[1,5-a]pyrimidine derivatives. Part 1: study of the structural features for BZR recognition.
    Selleri S; Bruni F; Costagli C; Costanzo A; Guerrini G; Ciciani G; Costa B; Martini C
    Bioorg Med Chem; 1999 Dec; 7(12):2705-11. PubMed ID: 10658575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of novel 2-phenyl-2H-pyrazolo[4,3-c]isoquinolin-3-ols: topological comparisons with analogues of 2-phenyl-2,5-dihydropyrazolo[4,3-c]quinolin-3(3H)-ones at benzodiazepine receptors.
    Allen MS; Skolnick P; Cook JM
    J Med Chem; 1992 Jan; 35(2):368-74. PubMed ID: 1310121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High affinity central benzodiazepine receptor ligands. Part 2: quantitative structure-activity relationships and comparative molecular field analysis of pyrazolo[4,3-c]quinolin-3-ones.
    Savini L; Chiasserini L; Pellerano C; Biggio G; Maciocco E; Serra M; Cinone N; Carrieri A; Altomare C; Carotti A
    Bioorg Med Chem; 2001 Feb; 9(2):431-44. PubMed ID: 11249135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationship studies of novel pyrazolo[1,5-c][1,3]benzoxazines: synthesis and benzodiazepine receptor affinity.
    Varano F; Catarzi D; Colotta V; Cecchi L; Filacchioni G; Galli A; Costagli C
    Arch Pharm (Weinheim); 1996 Dec; 329(12):529-34. PubMed ID: 9038420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of molecular pharmacophore/receptor models for GABAA/BzR subtypes: binding affinities of symmetrically substituted pyrazolo[4,3-c]quinolin-3-ones at recombinant alpha x beta 3 gamma 2 subtypes and quantitative structure-activity relationship studies via a comparative molecular field analysis.
    He X; Huang Q; Yu S; Ma C; McKernan R; Cook JM
    Drug Des Discov; 1999 Jul; 16(1):77-91. PubMed ID: 10466058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural requirements for agonist actions at the benzodiazepine receptor: studies with analogues of 6-(benzyloxy)-4-(methoxymethyl)-beta-carboline-3-carboxylic acid ethyl ester.
    Hollinshead SP; Trudell ML; Skolnick P; Cook JM
    J Med Chem; 1990 Mar; 33(3):1062-9. PubMed ID: 1968513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tricyclic heteroaromatic systems. Pyrazolo[3,4-c]quinolin-4-ones and pyrazolo[3,4-c]quinoline-1,4-diones: synthesis and benzodiazepine receptor activity.
    Catarzi D; Colotta V; Varano F; Cecchi L; Filacchioni G; Galli A; Costagli C
    Arch Pharm (Weinheim); 1997 Dec; 330(12):383-6. PubMed ID: 9474897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacophore/receptor models for GABA(A)/BzR subtypes (alpha1beta3gamma2, alpha5beta3gamma2, and alpha6beta3gamma2) via a comprehensive ligand-mapping approach.
    Huang Q; He X; Ma C; Liu R; Yu S; Dayer CA; Wenger GR; McKernan R; Cook JM
    J Med Chem; 2000 Jan; 43(1):71-95. PubMed ID: 10633039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of analogues of the partial agonist 6-(propyloxy)-4-(methoxymethyl)-beta-carboline-3-carboxylic acid ethyl ester (6-PBC) and the full agonist 6-(benzyloxy)-4-(methoxymethyl)-beta-carboline-3-carboxylic acid ethyl ester (Zk 93423) at wild type and recombinant GABAA receptors.
    Cox ED; Diaz-Arauzo H; Huang Q; Reddy MS; Ma C; Harris B; McKernan R; Skolnick P; Cook JM
    J Med Chem; 1998 Jul; 41(14):2537-52. PubMed ID: 9651158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quantitative structure-activity relationship study on some pyrazolo[4,5-c]quinolines acting as inhibitors of benzodiazepine-receptor binding.
    Gupta SP; Saha RN; Gupta JK; Singh P
    Res Commun Chem Pathol Pharmacol; 1989 Jul; 65(1):119-22. PubMed ID: 2551004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that 2-phenylpyrazolo[4,3-c]-quinolin-3(5H)-one antagonises pharmacological, electrophysiological and biochemical effects of diazepam in rats.
    Santi M; Pinelli G; Ricci P; Penne A; Zeneroli ML; Baraldi M
    Neuropharmacology; 1985 Feb; 24(2):99-105. PubMed ID: 2986034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variations on a scaffold - Novel GABA
    Iorio MT; Rehman S; Bampali K; Stoeger B; Schnürch M; Ernst M; Mihovilovic MD
    Eur J Med Chem; 2019 Oct; 180():340-349. PubMed ID: 31325782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biarylpyrazole inverse agonists at the cannabinoid CB1 receptor: importance of the C-3 carboxamide oxygen/lysine3.28(192) interaction.
    Hurst D; Umejiego U; Lynch D; Seltzman H; Hyatt S; Roche M; McAllister S; Fleischer D; Kapur A; Abood M; Shi S; Jones J; Lewis D; Reggio P
    J Med Chem; 2006 Oct; 49(20):5969-87. PubMed ID: 17004712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rat pup ultrasonic vocalization: effects of benzodiazepine receptor ligands.
    Olivier B; Molewijk E; van Oorschot R; van der Heyden J; Ronken E; Mos J
    Eur J Pharmacol; 1998 Oct; 358(2):117-28. PubMed ID: 9808260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel 3-aroylpyrazolo[5,1-c][1,2,4]benzotriazine 5-oxides 8-substituted, ligands at GABAA/benzodiazepine receptor complex: synthesis, pharmacological and molecular modeling studies.
    Guerrini G; Ciciani G; Cambi G; Bruni F; Selleri S; Melani F; Montali M; Martini C; Ghelardini C; Norcini M; Costanzo A
    Bioorg Med Chem; 2008 Apr; 16(8):4471-89. PubMed ID: 18325771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.